Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 89

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 89
---
 the Business Combination, please see the section of this proxy statement/prospectus entitled “The Business Combination Proposal—The Business Combination Agreement and Related Agreements.” 8 In addition to the approval of the Business Combination Proposal, unless waived by the parties to the Business Combination Agreement in accordance with applicable law, the Closing of the Business Combination is subject to a number of conditions set forth in the Business Combination Agreement. For more information about the closing conditions to the Business Combination, see the section of this proxy statement/prospectus titled “The Business Combination Proposal—Conditions to the Consummation of the Business Combination.” Proposal 3: The Merger Proposal In connection with the Business Combination, Finnovate is asking Finnovate shareholders to consider and vote upon and to approve a proposal to approve and authorize the Second Merger and the plan of merger in connection with the Second Merger, a copy of which is included as Annex B to the accompanying proxy statement/prospectus (the “Plan of Merger”), and any and all transactions provided for in the Plan of Merger, including, without limitation, at the effective time of the Second Merger (the “Effective Time”) (a) the amendment and restatement of the Finnovate Articles by deletion in their entirety and the substitution in their place of the new amended and restated memorandum and articles of association of Finnovate (as the Surviving Entity) (the “Surviving Entity Articles”) and (b) the redesignation of all authorized class A ordinary shares of US$0.0001 par value each of Finnovate as ordinary shares of US$0.0001 par value each of the Surviving Entity, and cancel all of the authorized but unissued class B ordinary shares of US$0.0001 par value each and preference shares of US$0.0001 par value each of Finnovate, such that the authorized share capital of the Surviving Entity will become US$50,000 divided into 500,000,000 ordinary shares of a par value of US$0.0001 per share, with such rights, privileges and conditions as set out in the Surviving Entity Articles be approved and authorized in all respects. Pursuant to the Business Combination Agreement, at the Effective Time, an amended and restated memorandum and articles of association of Surviving Entity, which will be substantially in the form of the memorandum and articles of association of Merger Sub II, as in effect immediately prior to the Effective Time shall be adopted and filed and that Finnovate